Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices

Bibliographic Citation

United States. Department of Health and Human Services. Food and Drug Administration [FDA]. Office of the Commissioner, Office of Policy January, 2009. 8p. [Online]. Accessed: http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126.htm [2009 October 2]

Permanent Link

Find in a Library
http://timetravel.mementoweb.org/memento/2009/http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126.htm
http://hdl.handle.net/10822/952300

Date

2009-01

Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices

Bibliographic Citation

Permanent Link

Date

Subject

Collections

Metadata

Related items

Off-Label or Out of Bounds? Prescriber and Marketer Liability for Unapproved Uses of FDA-Approved Drugs ﻿

Double-Duty Drugs: Approved Medications Are Being Widely Prescribed for Unapproved Uses ﻿

Guidance for the Emergency Use of Unapproved Medical Devices; Availability ﻿

Off-Label or Out of Bounds? Prescriber and Marketer Liability for Unapproved Uses of FDA-Approved Drugs

Double-Duty Drugs: Approved Medications Are Being Widely Prescribed for Unapproved Uses

Guidance for the Emergency Use of Unapproved Medical Devices; Availability